INGRY VO: Open Payments
NPI 1780178392 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 5 payments from 5 companies in 2025. Trend: 2023 $554 · 2024 $522 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| SHIELD THERAPEUTICS INC | 1 | $29 |
| Novo Nordisk Inc | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $17 |
Products named: ZERBAXA, BEXSERO, ACCRUFER, Wegovy, BEYFORTUS.
Industry payments across CA — which companies pay providers there.
